QIAGEN
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
QGEN Key Statistics
Stock Snapshot
As of today, QIAGEN(QGEN) shares are valued at $43.23. The company's market cap stands at 9.05B, with a P/E ratio of 21.84 and a dividend yield of 0.81%.
During the trading session on 2026-08-13, QIAGEN(QGEN) shares reached a daily high of $43.79 and a low of $43.05. At a current price of $43.23, the stock is +0.4% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 3.05M, compared to an average daily volume of 3M.
The stock's 52-week range extends from a low of $32.53 to a high of $57.82.
The stock's 52-week range extends from a low of $32.53 to a high of $57.82.
QGEN News
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Image source: The Motley Fool. Thursday, Aug. 6, 2026 at 9:30 a.m. ET CALL PARTICIPANTS Vice President, Head of Investor Relations - Daniel Wendorff Chief Exec...
Qiagen ((QGEN)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks...
Analyst ratings
55%
of 22 ratingsMore QGEN News
The FDA clearance of Qiagen (QGEN) QIAstat-Dx BCID GPF Plus AMR Panel for bloodstream infections, together with the company exceeding its second quarter outlook...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
QIAGEN (QGEN) announced that the U.S. Food and Drug Administration has cleared the QIAstat-Dx BCID GPF Plus AMR Panel, the first QIAstat-Dx panel for bloodstrea...
Stifel analyst Daniel Arias raised the firm’s price target on Qiagen (QGEN) to $40 from $36 and keeps a Hold rating on the shares. Unlock powerful investing to...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.